Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
CMG Pharmaceutical Faces Delisting Risk Over Minimum Share Price Requirement

CMG Pharmaceutical Faces Delisting Risk Over Minimum Share Price Requirement

BitgetBitget2026/10/30 10:42
  • CMG Pharmaceutical faces delisting unless common shares close at 1,000 won or higher for 45 consecutive trading days within a 90-trading-day period.
  • The stock was designated for administrative supervision on Aug. 13, 2026, following 30 consecutive trading days with closing prices below 1,000 won.
  • As of Oct. 29, 36 trading days had elapsed since designation; shares had met the price threshold for four consecutive trading days.
  • A closing price below 1,000 won from the 46th trading day following designation could trigger delisting under Kosdaq listing rules.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CMG Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030901384), on October 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hassett Downplays AI Debt Risk: The Industry Has Sufficient Funds, No Risk of Broad Sell-Off

Kevin Hassett, Director of the White House National Economic Council, stated that the recent substantial decline in technology stocks does not indicate a comprehensive sell-off risk for the AI industry. He acknowledged that some enterprises are indeed burdened with significant debt, which warrants attention. However, he also pointed out that there are many financially strong companies within the industry that hold both equity and debt in related firms; these companies may be poised to acquire or provide funding support when opportunities arise.

华尔街见闻•2026/11/02 20:01
Hassett Downplays AI Debt Risk: The Industry Has Sufficient Funds, No Risk of Broad Sell-Off